Shariah compliance overview
HalalNovocure Ltd (NVCR) is currently classified as Halal by Akinda Shariah screening (AAOIFI-aligned methodology).
About Novocure Ltd
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally.
Novocure Ltd (NVCR) operates in the Healthcare sector, in the Medical - Devices industry.
Why it is halal: it passes all three AAOIFI screens. Non-compliant revenue is 2.69% (limit 5%), interest-bearing debt is 13.71% (limit 30%) and interest-bearing securities and assets are 25.26% (limit 30%).
If you hold NVCR, give 2.69% of the dividends you receive to charity to purify the non-compliant share of its income.
- Business Activity
- 2.69%Limit 5%Pass
- Interest-bearing debt
- 13.71%Limit 30%Pass
- Interest-bearing securities and assets
- 25.26%Limit 30%Pass
- Dividend purification
- 2.69%Share of dividends to give to charityPurification calculator
Last updated: Nov 3, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.
Please login to access this content
Please login to access this content
Please login to access this content
Company Profile
Please login to access this content
Frequently asked questions
Quick answers about Novocure Ltd (NVCR). Current Akinda screening label: Halal.
